Practical aspects of metastatic castration-resistant prostate cancer management: patient case studies-Reference-Cited by-同舟云学术

Practical aspects of metastatic castration-resistant prostate cancer management: patient case studies

Published:2012-01-19 Issue: Volume:109 Page:14-19
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:

Author:

Bahl Amit,Bellmunt Joaquim,Oudard Stéphane

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.2011.10872.x/fullpdf

Reference18 articles.

1. Steroid hormone receptors in prostate cancer: a hard habit to break?;Attard;Cancer Cell,2009

2. EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer;Mottet;Eur Urol,2011

3. US Food and Drug Administration. http://www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDER/ucm216214.htm 2011

4. European Medicines Agency. Jevtana (cabazitaxel) http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002018/human_med_001428.jsp&murl=menus/medicines/medicines.jsp&mid=WC0b01ac058001d124 2011

5. Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial;de Bono;Lancet,2010

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Economic evaluation of sipuleucel-T immunotherapy in castration-resistant prostate cancer;Expert Review of Anticancer Therapy;2014-01

2. Metastatic castrate-resistant prostate cancer: a discussion of the physical and psychosocial effects;International Journal of Urological Nursing;2013-01-24